Halfway There in Developing Obesity Care?
August 9, 2015 — Progress in developing obesity care options is very encouraging, and at the same time frustrating. Friday, Novo Nordisk reported on early results from introducing Saxenda — the fourth new obesity treatment in as many years — into the U.S. Uptake is encouraging, with prescriptions that are growing steadily at a volume comparable to other recent introductions. For […]
